CRT 2025
Technology and Innovation
FDA Valve and Structural Town Hall
Megan Coylewright, MD, MPH
Editor
American College of Cardiology CardioSmart, Tennessee, United States
Disclosure(s): Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)
Aaron V. Kaplan, MD, FSCAI, FACC, FNAI
Professor of Medicine
Dartmouth Health
Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States
Disclosure information not submitted.
Haim Danenberg, MD
Head of interventional cardiology
Wolfson Medical Center
Holon, Israel
Disclosure information not submitted.
Creighton W. Don, MD
Professor of Medicine/Cardiology
Director of the Interventional Cardiology and Structural Heart Fellowships
University of Washington
Seattle, Washington, United States
Disclosure(s): No financial relationships to disclose
Kenneth A. Ellenbogen, MD
Professor
VCU School of Medicine
Richmond, Virginia, United States
Disclosure(s): No financial relationships to disclose
Saibal Kar, MD, FSCAI, FACC
Director of Structural Heart Disease, Interventions and Research
Physician Director, Interventional Cardiology, HCA Healthcare
HCA-Los Robles Regional Medical Center, Thousand Oaks, CA
Thousand Oaks, California, United States
Disclosure information not submitted.
Devi G. Nair, MD , FACC, FHRS
Director of Cardiac Electrophysiology
St. Bernards Medical Center
JONESBORO, Arkansas, United States
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Horst Sievert, MD, FSCAI, FACC, FESC
Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany
Disclosure(s): Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)
Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI
Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.
US Heart & Vascular, Tucson Medical Center
Disclosure(s): No financial relationships to disclose